Physiogenomic comparison of edema and BMI in patients receiving rosiglitazone or pioglitazone
about
Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) studyPhysiogenomic analysis of the Puerto Rican population.Genetic associations of brain structural networks in schizophrenia: a preliminary studyPharmacogenomics and pharmacogenetics of thiazolidinediones: role in diabetes and cardiovascular risk factors.Physiogenomic analysis of CYP450 drug metabolism correlates dyslipidemia with pharmacogenetic functional status in psychiatric patientsAPOH interacts with FTO to predispose to healthy thinnessGenome-wide significant results identified for plasma apolipoprotein H levels in middle-aged and older adults.Current clinical evidence on pioglitazone pharmacogenomics.The safety of thiazolidinediones.PPAR agonists for the treatment of cardiovascular disease in patients with diabetes.Saroglitazar for the treatment of dyslipidemia in diabetic patients.Effects of Combination of Thiazolidinediones with Melatonin in Dexamethasone-induced Insulin Resistance in Mice.Exploring single nucleotide polymorphisms previously related to obesity and metabolic traits in pediatric-onset type 2 diabetes.
P2860
Q24601415-FDA128A9-5075-41FA-A185-89C6552F6CB1Q33758504-4E5FAFC5-4DB7-4496-9D3E-759CB0255EB2Q34343604-687E3885-166C-4DBE-AFDA-61BEF58ECE31Q35039274-E3EFE10C-3D8F-45B5-956E-509B2588F8CAQ35575577-7DDF4AA0-0EBF-4573-8C08-1747ED050D90Q36470484-79B289E7-078F-4CFE-BD6E-7DE4CBA99622Q36748126-B3EE5BF3-3B5D-40B9-BAD1-7D32ACBC7C67Q37342358-BD7CAA38-C073-4E2C-BA5C-F5D0DAE192D2Q37848841-7D90C4F1-0C5D-45CD-AA81-071CADA2A760Q37996437-3F8A7EBA-8FF4-4A7C-950F-6EBC1889DB62Q38352759-BDA59C61-46B2-4AD0-867A-32DC3C8EDA8EQ42080920-D2C62DC3-FFDE-4232-916F-4B668F5837D1Q47915636-6DD57325-F92C-49DC-AE27-B02C1864E087
P2860
Physiogenomic comparison of edema and BMI in patients receiving rosiglitazone or pioglitazone
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Physiogenomic comparison of ed ...... rosiglitazone or pioglitazone
@ast
Physiogenomic comparison of ed ...... rosiglitazone or pioglitazone
@en
Physiogenomic comparison of ed ...... rosiglitazone or pioglitazone
@nl
type
label
Physiogenomic comparison of ed ...... rosiglitazone or pioglitazone
@ast
Physiogenomic comparison of ed ...... rosiglitazone or pioglitazone
@en
Physiogenomic comparison of ed ...... rosiglitazone or pioglitazone
@nl
prefLabel
Physiogenomic comparison of ed ...... rosiglitazone or pioglitazone
@ast
Physiogenomic comparison of ed ...... rosiglitazone or pioglitazone
@en
Physiogenomic comparison of ed ...... rosiglitazone or pioglitazone
@nl
P2093
P3181
P1433
P1476
Physiogenomic comparison of ed ...... rosiglitazone or pioglitazone
@en
P2093
Andreas Windemuth
Bruce Bower
Detlef Wencker
Gualberto Ruaño
James Bernene
Mohan Kocherla
Richard L Seip
Steven Hanks
William A Petit
P3181
P356
10.1016/J.CCA.2008.10.009
P407
P577
2009-02-01T00:00:00Z